Published in Curr Infect Dis Rep on February 02, 2012
Alkaline phosphatases contribute to uterine receptivity, implantation, decidualization, and defense against bacterial endotoxin in hamsters. Reproduction (2013) 0.81
A major determinant for gliding motility in Mycoplasma genitalium: the interaction between the terminal organelle proteins MG200 and MG491. J Biol Chem (2014) 0.77
Same-day intrauterine device placement is rarely complicated by pelvic infection. Womens Health Issues (2014) 0.75
Vaginal use of Ibuprofen isobutanolammonium (ginenorm): efficacy, tolerability, and pharmacokinetic data: a review of available data. ISRN Obstet Gynecol (2012) 0.75
RNA Biosignatures in Adolescent Patients in a Pediatric Emergency Department With Pelvic Inflammatory Disease. Pediatr Emerg Care (2015) 0.75
Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep (2010) 14.85
Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis (1992) 5.19
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol (1975) 4.86
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol (2002) 4.18
Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol (1969) 3.91
Association between Mycoplasma genitalium and acute endometritis. Lancet (2002) 3.27
Criteria for diagnosis and grading of salpingitis. Obstet Gynecol (1983) 2.37
Pelvic inflammatory disease in human immunodeficiency virus-infected women. Obstet Gynecol (1993) 2.05
A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol (2003) 1.97
A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol (2005) 1.94
Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol (1993) 1.92
Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol (1990) 1.88
Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol (2002) 1.85
Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis (1988) 1.83
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol (1996) 1.72
Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother (2004) 1.67
Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect (2005) 1.65
Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65
Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis (2004) 1.65
Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1989) 1.62
Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol (2005) 1.60
Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol (1997) 1.55
Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials. Clin Infect Dis (2007) 1.47
Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA (1983) 1.46
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis (2005) 1.40
Transvaginal ultrasonographic study of the fallopian tube. Obstet Gynecol (1987) 1.39
Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet Gynecol (1995) 1.34
Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease. J Clin Pathol (2003) 1.33
Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol (2000) 1.30
Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect (2008) 1.30
Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med (1986) 1.30
Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis (1995) 1.25
Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol (1994) 1.21
Bacterial vaginosis and risk of pelvic inflammatory disease. Obstet Gynecol (2004) 1.20
Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis (2009) 1.15
Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J Infect Dis (1998) 1.15
Detection of novel organisms associated with salpingitis, by use of 16S rDNA polymerase chain reaction. J Infect Dis (2004) 1.12
MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology (1999) 1.10
Sexually transmitted diseases. Pelvic inflammatory disease and infertility in women. Infect Dis Clin North Am (1987) 1.09
Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA (1991) 1.08
Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol (1996) 1.04
Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res (2003) 1.01
Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease. Obstet Gynecol (2003) 1.00
Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am J Obstet Gynecol (1999) 1.00
Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstet Gynecol (2007) 0.99
Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment. J Infect Dis (2005) 0.97
Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther (2006) 0.95
Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet Gynecol (2000) 0.94
Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis (2005) 0.93
Pelvic inflammatory disease during pregnancy. South Med J (1987) 0.92
Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis. Obstet Gynecol (1994) 0.92
Serum CA 125 levels in patients with a provisional diagnosis of pelvic inflammatory disease. Clinical and theoretical implications. Acta Obstet Gynecol Scand (1989) 0.91
Influence of an intrauterine device on the course of an acute salpingitis. Contraception (1981) 0.88
Effect of human immunodeficiency virus-1 infection on treatment outcome of acute salpingitis. Obstet Gynecol (2006) 0.84
A practical approach to the diagnosis of pelvic inflammatory disease. Infect Dis Obstet Gynecol (2011) 0.81
Diagnosis and treatment of pelvic inflammatory disease. Womens Health (Lond Engl) (2008) 0.80
Serum CA-125 in the diagnosis of acute pelvic inflammatory disease. Int J Gynaecol Obstet (1994) 0.80
Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis (2007) 0.79
European guideline for the management of pelvic inflammatory disease. Int J STD AIDS (2007) 0.79
Clinical utility of CA125 levels in predicting laparoscopically confirmed salpingitis in patients with clinically diagnosed pelvic inflammatory disease. Infect Dis Obstet Gynecol (1998) 0.79
Serum CRP in the diagnosis and treatment of pelvic inflammatory disease. Arch Gynecol Obstet (1987) 0.78
Concerns regarding the Centers for Disease Control's published guidelines for pelvic inflammatory disease. Clin Infect Dis (2000) 0.78
Surgical considerations in the diagnosis and treatment of pelvic inflammatory disease. Surg Clin North Am (1991) 0.77
Acute suppurative salpingitis with concomitant intrauterine pregnancy. Am J Emerg Med (1993) 0.76
Cost-effectiveness of alternative outpatient pelvic inflammatory disease treatment strategies. Sex Transm Dis (2007) 0.76